39EGP
- Active ingredient
- trimetazidine
- Strength
- 20 mg
- Form
- tablet
- Manufacturer
- global napi pharmaceuticals
- Route
- oral.solid
Uses
Used as adjunctive therapy for stable angina pectoris when symptoms are inadequately controlled by first-line treatments.
Do not use if
Contraindicated in Parkinson's disease, movement disorders, and severe renal impairment.
Side effects
May cause dizziness, headache, nausea, abdominal pain, and fatigue.
Warnings
Discontinue if movement disorders develop.
How it works
Improves myocardial energy metabolism by shifting cellular energy utilization toward glucose oxidation.
Storage
Store at room temperature.